|
San Antonio, TX -SABCS 2007: Lori Goldstein of presents a paper on ?Prognostic utility of the 21-gene assay compared with Adjuvant! in hormone receptor (HR) positive operable breast cancer with 0-3 positive axillary nodes treated with adjuvant chemohormonal therapy (CHT): an analysis of intergroup trial E2197? during the GENERAL SESSION 6 at the San Antonio Breast Cancer Symposium here today, Saturday December 15, 2007 in the Henry Gonzalez Convention Center. Over 8,000 physicians, researchers, clinicians, caregivers and cancer survivors from over 60 countries gathered to hear the latest developments in Breast Cancer research and treatment. Date: Saturday December 15, 2007 Photo by © SABCS/Todd Buchanan 2007 Technical Questions: todd@toddbuchanan.com; Phone: 612-226-5154.
|